Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.

Li Z, Chen Y, An T, Liu P, Zhu J, Yang H, Zhang W, Dong T, Jiang J, Zhang Y, Jiang M, Yang X

DOI: 10.1186/s13046-019-1134-y
Published: 2019 Mar 29
Container: Journal of experimental & clinical cancer research : CR
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13046-019-1134-y,
  title = {Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.},
  author = {Li Z and Chen Y and An T and Liu P and Zhu J and Yang H and Zhang W and Dong T and Jiang J and Zhang Y and Jiang M and Yang X},
  year = {2019},
  journal = {Journal of experimental \& clinical cancer research : CR},
  doi = {10.1186/s13046-019-1134-y},
  url = {https://doi.org/10.1186/s13046-019-1134-y}
}

RIS

TY  - JOUR
TI  - Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
AU  - Li Z
AU  - Chen Y
AU  - An T
AU  - Liu P
AU  - Zhu J
AU  - Yang H
AU  - Zhang W
AU  - Dong T
AU  - Jiang J
AU  - Zhang Y
AU  - Jiang M
AU  - Yang X
PY  - 2019
JO  - Journal of experimental & clinical cancer research : CR
DO  - 10.1186/s13046-019-1134-y
UR  - https://doi.org/10.1186/s13046-019-1134-y
ER  -

APA

Z, L., Y, C., T, A., P, L., J, Z., H, Y., W, Z., T, D., J, J., Y, Z., M, J., & X, Y. (2019). Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-019-1134-y

Source records

pubmed · retrieved 2026-09-26T15:23:44.639Z